The Past Decade of Experience With Isolated Hepatic Perfusion

The Past Decade of Experience With Isolated Hepatic Perfusion Amelia Grover, H. Richard Alexander, Jr. Oncologist 2004; 9: 653-664 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in hepatobiliary cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the principles of regional therapy for unresectable primary or metastatic cancer confined to the liver. Explain the principles of isolation perfusion of the liver. Describe the efficacy and toxicity of isolation perfusion of the liver. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Nov. 23, 2004 Most Recent Review: Nov. 23, 2004* Most Recent Update: Nov. 23, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.